<DOC>
	<DOCNO>NCT01089218</DOCNO>
	<brief_summary>Fever develop fiberoptic bronchoscopy ( FB ) 2.5 - 16 % adult patient . We evaluate impact oral amoxicillin/clavulanate ( AC ) incidence postbronchoscopic fever pneumonia .</brief_summary>
	<brief_title>The Impact Antibiotic Prophylaxis Incidence Post-bronchoscopy Fever Change Serum Cytokines</brief_title>
	<detailed_description>For population undergone bronchoscopy , clinical sign procedural measure complication bronchoscopy cytokine check .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>adult patient ( age 18 year old ) underwent FB concurrent treatment antibiotic systemic corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>bronchoscopy</keyword>
	<keyword>post-bronchoscopy fever</keyword>
	<keyword>pneumonia</keyword>
	<keyword>cytokine</keyword>
	<keyword>amoxicillin/clavulanate</keyword>
	<keyword>prophylaxis</keyword>
</DOC>